
Biotechnology Firm Scribe Therapeutics Files for Nasdaq IPO
Scribe Therapeutics, a biotechnology company, has submitted a registration statement for an initial public offering on the Nasdaq Global Market. The company plans to trade under the ticker symbol 'SCTX' but has not yet disclosed the size or price of the offering.







